Intrinsic Value

505 doesn't have a meaningful market cap.

The intrinsic value of AsiaMedic Ltd (505) under the Base Case is 0.028 SGD per share. Compared with the current market price of 0.017 SGD, the stock appears Undervalued by 39% .

The intrinsic value is calculated using the DCF method. The model mostly extends the recent record: revenue grows about 16% a year over the next five years, against 18% over the last five, and operating margin stays near last year's 2.8%. If revenue grew at its five-year pace of 18%, the estimate would be about S$0.05.

Do our valuations actually work? See backtest results .

Intrinsic Value
S$0.028
Undervaluation 39%
Intrinsic Value
Price S$0.017
Alert me when AsiaMedic Ltd is below its intrinsic value
Today S$0.017 · 2.0% below the current price

AsiaMedic Ltd is cheaper than usual. It was this cheap or cheaper on less than 1% of days in the past 5 years.

Alternatives to AsiaMedic Ltd

Fundamental Analysis

What AsiaMedic Does

Health Care

AsiaMedic Ltd is a Singapore-based healthcare provider best known for diagnostic imaging, health screening, and specialist outpatient services. It serves patients, employers, and medical referral partners who need scans, preventive checkups, and doctor consultations rather than hospital admission. Its core work is to help doctors find and monitor health problems early, using medical imaging and screening services as the front line of care.

Headquarters
Singapore SG
IPO date
Feb 1, 1988
Read the full company overview
View Company Overview
Financials
Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Continue Research

Decided on AsiaMedic? Get an email when AsiaMedic Ltd reaches the price you’d buy at. Free with an account.

What is the Intrinsic Value of one AsiaMedic Ltd stock?

The intrinsic value for AsiaMedic Ltd (505) under the Base Case is 0.028 SGD.

Is AsiaMedic Ltd stock undervalued or overvalued?

Compared with the current market price of 0.017 SGD, the stock appears Undervalued by 39% .

How reliable are our estimates? See how past valuations played out
Back to Top